Bowing to pressure from Congress, the FDA has decided not to close more than half of its field labs. The ill-timed plan to consolidate seven of the agency’s thirteen labs in the name of efficiency and modernization was already under review by a Presidential panel, and had raised the ire of the powerful Chairman of the House Energy and Commerce Committee, John Dingell, who recently introduced legislation to block the reorganization.